Long-term outcomes and improved risk of revision following tumor endoprosthetic replacement of the distal femur: Single institutional results
| Autor: | Joshua A. Greenspoon, Bishir Clayton, Jonathan Bauer, Steven Gitelis, Charles A Gusho, Matthew W. Colman, Alan T. Blank |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
030222 orthopedics
medicine.medical_specialty business.industry Incidence (epidemiology) Retrospective cohort study 030229 sport sciences Evidence-based medicine Article Surgery 03 medical and health sciences Distal femur 0302 clinical medicine medicine Long term outcomes Orthopedics and Sports Medicine Cumulative incidence Revision rate Implant business |
| Zdroj: | J Orthop |
| ISSN: | 0972-978X |
| DOI: | 10.1016/j.jor.2021.05.027 |
| Popis: | Purpose This study assessed revision characteristics following distal femur tumor endoprosthetic replacement. Methods Fifty-seven procedures were performed between 2005 and 2019. The cumulative incidence of implant revision was calculated with death as a competing risk. Results The all-cause revision rate was 21.1% (n = 12) at a mean 65.3 ± 47.3 months. Competing risk analysis revealed a cumulative revision incidence of 12.0% (95% CI, 3.6–25.9%) at five years and 36.5% (95% CI, 12.8–61.0%) at ten years. Conclusions We provide an accurate assessment of revision risk which is slightly lower than historical controls, with identification of failure modes to reliably inform patient expectations. Level of evidence III. Retrospective Study. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect